+

WO2007026035A3 - Aminoacide de type mycosporine (porphyre 334) utilise comme antioxydant - Google Patents

Aminoacide de type mycosporine (porphyre 334) utilise comme antioxydant Download PDF

Info

Publication number
WO2007026035A3
WO2007026035A3 PCT/ES2006/000488 ES2006000488W WO2007026035A3 WO 2007026035 A3 WO2007026035 A3 WO 2007026035A3 ES 2006000488 W ES2006000488 W ES 2006000488W WO 2007026035 A3 WO2007026035 A3 WO 2007026035A3
Authority
WO
WIPO (PCT)
Prior art keywords
porphyra
mycosporin
amino acid
antioxidant
type amino
Prior art date
Application number
PCT/ES2006/000488
Other languages
English (en)
Spanish (es)
Other versions
WO2007026035A2 (fr
Inventor
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Original Assignee
Univ Malaga
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaga, La Coba Luque Francisca De, Arjona Jose Aguilera, Figueroa Felix Lopez filed Critical Univ Malaga
Publication of WO2007026035A2 publication Critical patent/WO2007026035A2/fr
Publication of WO2007026035A3 publication Critical patent/WO2007026035A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Psychology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention porte sur un aminoacide de type mycosporine (porphyre 334) utilisé comme antioxydant. L'invention concerne le secteur biotechnologique et décrit l'utilisation éventuelle d'un aminoacide de type mycosporine (MAA), en particulier de la porphyre 334 isolée de l'algue rouge Porphyra leucostica, comme substance antioxydante. L'invention concerne également l'utilisation éventuelle dudit aminoacide dans des préparations pharmaceutiques, nutritionnelles ou dans des aliments fonctionnels, notamment pour la prévention du stress oxydatif.
PCT/ES2006/000488 2005-08-31 2006-08-28 Aminoacide de type mycosporine (porphyre 334) utilise comme antioxydant WO2007026035A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200502161A ES2301293B1 (es) 2005-08-31 2005-08-31 Uso de aminoacido tipo micosporina (porphyra 334) como antioxidante.
ESP200502161 2005-08-31

Publications (2)

Publication Number Publication Date
WO2007026035A2 WO2007026035A2 (fr) 2007-03-08
WO2007026035A3 true WO2007026035A3 (fr) 2007-05-10

Family

ID=37809229

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2006/000488 WO2007026035A2 (fr) 2005-08-31 2006-08-28 Aminoacide de type mycosporine (porphyre 334) utilise comme antioxydant

Country Status (2)

Country Link
ES (6) ES2301437B1 (fr)
WO (1) WO2007026035A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2317741B1 (es) * 2006-06-20 2010-02-10 Universidad De Malaga Composicion para proteccion solar a base de extractos de algas y liquenes.
KR102196422B1 (ko) * 2019-07-15 2020-12-30 주식회사 바이오에프디엔씨 포피라334를 이용한 성체세포를 유도만능 줄기세포로 역분화시키는 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024369A1 (fr) * 1998-10-23 2000-05-04 Nouvab Inc Composition de protection contre le rayonnement solaire
WO2002039974A1 (fr) * 2000-11-17 2002-05-23 Natural Environment Research Council Compositions de soins personnels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655268B1 (fr) * 1989-12-06 1994-10-14 Secma Utilisation d'extraits d'algues pour la preparation de compositions pharmaceutiques, cosmetiques, alimentaires ou a usage agricole.
FR2803201B1 (fr) * 1999-12-30 2004-11-26 Gelyma Extrait d'algue a activite filtrante vis a vis des radiations ultraviolettes
CA2467102C (fr) * 2001-11-14 2012-07-10 Larena Un produit contenant un extrait d'algue rouge du genre porphyra et ses utilisations pour proteger les cellules
FR2882894B1 (fr) * 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024369A1 (fr) * 1998-10-23 2000-05-04 Nouvab Inc Composition de protection contre le rayonnement solaire
WO2002039974A1 (fr) * 2000-11-17 2002-05-23 Natural Environment Research Council Compositions de soins personnels

Also Published As

Publication number Publication date
ES2301436B1 (es) 2009-05-08
ES2301435A1 (es) 2008-06-16
ES2301293A1 (es) 2008-06-16
ES2301436A1 (es) 2008-06-16
ES2301293B1 (es) 2009-05-01
ES2301434A1 (es) 2008-06-16
ES2301437A1 (es) 2008-06-16
ES2301435B1 (es) 2009-05-01
ES2301434B1 (es) 2009-05-01
ES2301433A1 (es) 2008-06-16
WO2007026035A2 (fr) 2007-03-08
ES2301437B1 (es) 2009-05-01

Similar Documents

Publication Publication Date Title
WO2003041679A3 (fr) Produit contenant un extrait d'algue rouge du genre porphyra
Tanzadehpanah et al. An antioxidant peptide derived from Ostrich (Struthio camelus) egg white protein hydrolysates
WO2011100763A3 (fr) Compositions de supplément alimentaire pour ruminants et procédés de fabrication et d'utilisation associés
WO2009017840A9 (fr) Compositions contenant une protéine et un produit d'acide aminé isolé ou purifié et utilisations de celles-ci
WO2008036932A3 (fr) Compositions et procédés utilisant l'espèce boswellia
WO2007079139A3 (fr) Formes solides de n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoléine-3-carboxamide
Nwachukwu et al. Antioxidant properties of flaxseed protein hydrolysates: influence of hydrolytic enzyme concentration and peptide size
WO2007059715A3 (fr) Methodes et proteines destinees au traitement prophylactique et/ou therapeutique des quatre serotypes du virus de la dengue et autres flavivirus
WO2010130832A3 (fr) Séquences d'acides aminés dirigées contre dickkopf-1 et polypeptides comprenant ces dernières pour le traitement de maladies et de pathologies associées à la déperdition osseuse et/ou à l'ostéolyse
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
ATE402143T1 (de) Verfahren zum erhalten neuer formulierungen auf luteinbasis
WO2011152330A1 (fr) Anti-oxydant contenant un hydrolysat de protéine de soja, et son utilisation
CO5700787A2 (es) Composiciones con un contenido de enzimas, alimentos dieteticos y medicamentos producidos a partir de ellas, y su utilizacion para finalidades medicinales
WO2005082927A3 (fr) Peptides utilises contre l'hypertension
WO2006034172A3 (fr) Fractions de proteines vegetales riches en glycinine et ?eta-conglycinine
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
Alu'datt et al. Antioxidant and antihypertensive properties of phenolic–protein complexes in extracted protein fractions from Nigella damascena and Nigella arvensis
WO2007137297A3 (fr) Aliments et boissons contenant des additifs
WO2006042661A3 (fr) Oligopeptides et utilisations
WO2007026035A3 (fr) Aminoacide de type mycosporine (porphyre 334) utilise comme antioxydant
WO2003050067A3 (fr) Analogues de la vitamine d
NZ585092A (en) Food material for inhibiting osteoclastogenesis
WO2009037183A3 (fr) Préparation cosmétique et/ou pharmaceutique contenant des acides nucléiques destinée à la production de peptides antimicrobiens dans des tissus épithéliaux
WO2007014379A3 (fr) Extrait lipidique provenant de lepidium meynii et effet de celui-ci sur la libido
WO2007026036A3 (fr) Aminoacide de type mycosporine (m-gly) utilise comme antioxydant

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06807933

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载